Show simple item record

dc.contributor.advisorEgieyeh, Samuel
dc.contributor.authorIlori, Tosin Lydia
dc.date.accessioned2024-01-23T10:27:31Z
dc.date.available2024-01-23T10:27:31Z
dc.date.issued2023
dc.identifier.urihttp://hdl.handle.net/11394/10621
dc.descriptionMagister Pharmaceuticae - MPharmen_US
dc.description.abstractOne of the crucial ways by which Staphylococcus aureus develops resistance to antibiotics is biofilm formation, a protective mechanism involving extracellular polymeric substance (EPS) matrix that shields microorganisms from the effects of antibiotics, mechanical forces, pH, and host immune responses. While some encouraging results point to the possible use of FDA-approved medications against biofilms, more research is needed due to sporadic and patchy data. The complex chemical diversity of natural compounds makes them a reservoir of bioactive molecules for drug discovery. This study seeks to identify effective potential antibiofilm compounds from a query dataset compiled from two African natural product databases (SANCDb and AfroDb). A database of known antibiofilm compounds was created from ChEMBL, PubChem, and other related databases while a query dataset of natural products was compiled for this study. The ligand similarity (LS) searches were unable to unequivocally identify distinct differences in the molecular structures and functional group moiety of the active and inactive compounds.en_US
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.subjectBiofilm-associated Proteinsen_US
dc.subjectCOVID-19en_US
dc.subjectDeoxyribonucleic Aciden_US
dc.subjectAntibiofilmen_US
dc.subjectBiosurfactanten_US
dc.titleIdentification of potential antibiofilm hit compounds from two African natural product database against multi-drug resistant staphylococcus aureus: an in silico studyen_US
dc.typeThesisen_US
dc.rights.holderUniversity of the Western Capeen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record